+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In Vitro Diagnostics Market Research Report by Component, by Application, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5123118
  • Report
  • September 2021
  • Region: United States
  • 83 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States In Vitro Diagnostics Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States In Vitro Diagnostics Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the In Vitro Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Component, the In Vitro Diagnostics Market was studied across Data Management Software, Instruments, Reagents & Kits, and Services.
  • Based on Technology, the In Vitro Diagnostics Market was studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis. The Clinical Chemistry is further studied across Basic Metabolic Panel, Electrolyte Panel, Lipid Profile, Liver Panel, Renal Profile, Specialty Chemical Tests, and Thyroid Function Panel. The Immunochemistry is further studied across Enzyme-Linked Immunosorbent Assay, Enzyme-Linked Immunospot Assays, Radioimmunoassay, Rapid Test, and Western Blotting. The Molecular Diagnostics is further studied across DNA Sequencing & Next-Generation Sequencing, Hybridization, Isothermal Nucleic Acid Amplification Technology, Microarray, and Polymerase Chain Reaction.
  • Based on Application, the In Vitro Diagnostics Market was studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.
  • Based on End User, the In Vitro Diagnostics Market was studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.
  • Based on State, the In Vitro Diagnostics Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the In Vitro Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States In Vitro Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States In Vitro Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States In Vitro Diagnostics Market?
4. What is the competitive strategic window for opportunities in the United States In Vitro Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the United States In Vitro Diagnostics Market?
6. What is the market share of the leading vendors in the United States In Vitro Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the United States In Vitro Diagnostics Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Technology Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. State Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. In Vitro Diagnostics Market, by Component
6.1. Introduction
6.2. Data Management Software
6.3. Instruments
6.4. Reagents & Kits
6.5. Services

7. In Vitro Diagnostics Market, by Technology
7.1. Introduction
7.2. Clinical Chemistry
7.2.1. Basic Metabolic Panel
7.2.2. Electrolyte Panel
7.2.3. Lipid Profile
7.2.4. Liver Panel
7.2.5. Renal Profile
7.2.6. Specialty Chemical Tests
7.2.7. Thyroid Function Panel
7.3. Coagulation & Hemostasis
7.4. Hematology
7.5. Immunochemistry
7.5.1. Enzyme-Linked Immunosorbent Assay
7.5.1.1. Chemiluminescence Immunoassays
7.5.1.2. Colorimetric Immunoassays
7.5.1.3. Fluorescence Immunoassays
7.5.2. Enzyme-Linked Immunospot Assays
7.5.3. Radioimmunoassay
7.5.4. Rapid Test
7.5.5. Western Blotting
7.6. Microbiology
7.7. Molecular Diagnostics
7.7.1. DNA Sequencing & Next-Generation Sequencing
7.7.2. Hybridization
7.7.3. Isothermal Nucleic Acid Amplification Technology
7.7.4. Microarray
7.7.5. Polymerase Chain Reaction
7.8. Urinalysis

8. In Vitro Diagnostics Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiology
8.4. Diabetes
8.5. Drug Testing
8.6. HIV/Aids
8.7. Infectious Diseases
8.8. Nephrology
8.9. Oncology

9. In Vitro Diagnostics Market, by End User
9.1. Introduction
9.2. Hospitals & Care Providers
9.3. Laboratories
9.4. Patient Self-Testing

10. California In Vitro Diagnostics Market
10.1. Introduction

11. Florida In Vitro Diagnostics Market
11.1. Introduction

12. Illinois In Vitro Diagnostics Market
12.1. Introduction

13. New York In Vitro Diagnostics Market
13.1. Introduction

14. Ohio In Vitro Diagnostics Market
14.1. Introduction

15. Pennsylvania In Vitro Diagnostics Market
15.1. Introduction

16. Texas In Vitro Diagnostics Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
FIGURE 3. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 4. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES IN VITRO DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
FIGURE 10. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2026
FIGURE 12. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 21. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 23. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, 2018-2026 (USD MILLION)
FIGURE 46. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 47. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, 2018-2026 (USD MILLION)
FIGURE 48. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 49. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 51. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, 2018-2026 (USD MILLION)
FIGURE 52. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 53. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, 2018-2026 (USD MILLION)
FIGURE 54. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 55. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2026 (USD MILLION)
FIGURE 56. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 57. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2026 (USD MILLION)
FIGURE 58. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 59. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, 2018-2026 (USD MILLION)
FIGURE 60. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 61. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
FIGURE 62. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 63. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 64. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 65. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, 2018-2026 (USD MILLION)
FIGURE 66. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 67. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, 2018-2026 (USD MILLION)
FIGURE 68. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 69. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, 2018-2026 (USD MILLION)
FIGURE 70. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 71. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2026 (USD MILLION)
FIGURE 72. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 73. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2026 (USD MILLION)
FIGURE 74. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 75. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, 2018-2026 (USD MILLION)
FIGURE 76. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 77. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 78. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 79. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2026
FIGURE 80. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD MILLION)
FIGURE 81. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 82. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
FIGURE 83. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 84. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 85. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 86. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, 2018-2026 (USD MILLION)
FIGURE 87. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 88. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, 2018-2026 (USD MILLION)
FIGURE 89. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 90. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
FIGURE 91. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 92. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, 2018-2026 (USD MILLION)
FIGURE 93. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 94. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 95. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 96. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 97. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 98. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2026
FIGURE 99. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2026 (USD MILLION)
FIGURE 100. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 101. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 102. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 103. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, 2018-2026 (USD MILLION)
FIGURE 104. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 105. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 106. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 107. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 108. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 109. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 110. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 111. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 112. UNITED STATES IN VITRO DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 113. UNITED STATES IN VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 114. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES IN VITRO DIAGNOSTICS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES IN VITRO DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY STATE, 2018-2026 (USD MILLION)
TABLE 35. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 38. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 40. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY STATE, 2018-2026 (USD MILLION)
TABLE 41. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 44. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 45. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 46. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 47. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 49. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 50. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. UNITED STATES IN VITRO DIAGNOSTICS MARKET: SCORES
TABLE 58. UNITED STATES IN VITRO DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 59. UNITED STATES IN VITRO DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 60. UNITED STATES IN VITRO DIAGNOSTICS MARKET: RANKING
TABLE 61. UNITED STATES IN VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 62. UNITED STATES IN VITRO DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 63. UNITED STATES IN VITRO DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 64. UNITED STATES IN VITRO DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 65. UNITED STATES IN VITRO DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 66. UNITED STATES IN VITRO DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 67. UNITED STATES IN VITRO DIAGNOSTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll